Fetal growth restriction is worse than extreme prematurity for the developing lung

Sophie Soudée1, Lucie Vuillemin, Corinne Alberti

  • 1Neonatal Intensive Care Unit, Hôpital Robert Debré, Assistance Publique-Hôpitaux de Paris, Université Paris Diderot, Sorbonne Paris Cité, Paris France.

Neonatology
|August 30, 2014
PubMed

Insights

Very preterm infants with intrauterine growth restriction (IUGR) face higher risks of neonatal mortality and chronic lung disease (CLD). This risk is greater than for extremely low gestational age (ELGA) infants or those appropriate for gestational age (AGA).

Area of Science:

  • Neonatal Medicine
  • Perinatal Research
  • Pediatric Pulmonology

Background:

  • Perinatal lung development is sensitive to inflammation and intrauterine growth restriction (IUGR), key risk factors for chronic lung disease (CLD) in preterm infants.
  • The comparative impact of extremely low gestational age (ELGA) versus IUGR on CLD and co-morbidities in very preterm infants requires further investigation.

Purpose of the Study:

  • To compare neonatal morbidity, including CLD, and mortality among three groups of very preterm infants.
  • Groups included: ELGA infants with normal birth weight (ELGA-AGA), very preterm infants with IUGR (<3rd percentile) (VLGA-IUGR), and very preterm infants appropriate for gestational age (VLGA-AGA) matched with VLGA-IUGR.

Main Methods:

  • Retrospective comparison of perinatal and neonatal characteristics across the three infant groups.
  • Exclusion of infants with major congenital anomalies.
  • Chronic lung disease (CLD) diagnosis based on supplemental oxygen or non-invasive ventilation at 36 weeks postmenstrual age.

Main Results:

  • Neonatal mortality was 35% higher in very preterm infants with IUGR (VLGA-IUGR) compared to ELGA-AGA infants, despite a 3-week difference in gestational age.
  • Very preterm infants with IUGR (VLGA-IUGR) were five times more likely to develop CLD than ELGA-AGA infants.
  • These associations remained significant after adjusting for antenatal steroids, gender, and respiratory distress syndrome.

Conclusions:

  • Very preterm infants with IUGR (VLGA-IUGR) exhibit increased risks for neonatal mortality and CLD.
  • These risks are elevated compared to both extremely low gestational age infants appropriate for gestational age (ELGA-AGA) and very preterm infants appropriate for gestational age (VLGA-AGA).
Abstract

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.2K
Breathing01:05

Breathing

The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
50.1K
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
1.7K
Atelectasis II: Pathophysiology01:10

Atelectasis II: Pathophysiology

Atelectasis develops when alveoli lose their air and collapse inward. Because lung tissue is naturally elastic, these air sacs shrink rather than remaining open. Collapsed alveoli are no longer ventilated, reducing their role in gas exchange. Blood flow may continue in these regions, creating a ventilation–perfusion mismatch. Clinical findings include decreased breath sounds, dullness to percussion, reduced chest expansion, and decreased tactile fremitus as sound transmission through...
25
Fetal Circulation01:14

Fetal Circulation

Fetal circulation is a unique system that facilitates the exchange of gases, nutrients, and waste products between the developing fetus and the mother. This intricate process takes place through a special organ called the placenta.
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
5.0K
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
29